youtor.org
Treatment With Eribulin Mesylate in Metastatic Breast Cancer
>> YOUR LINK HERE: ___ http://youtube.com/watch?v=4Sc_faVVBp8
In this segment, panelists explore the cytotoxic agent eribulin mesylate, which has been the focus of several recent clinical trials. In all, despite a growing focus on targeted therapies, cytotoxics remain an important class of drugs in the treatment of patients with metastatic breast cancer. • To view more from this discussion, visit http://www.onclive.com/peer-exchange/...
#############################
